Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-22

Clinical Trial Update: Tailored Therapy for Clarithromycin-Resistant H. Pylori [NA]

View source ↗

Summary

A completed clinical trial evaluating tailored therapy for clarithromycin-resistant Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kangdong Sacred Heart Hospital | Conditions: Helicobacter Pylori Infection | NA | Status: COMPLETED